Evidence map›Paper›PMID 31505635›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.

Mouhamadou A Sonko, Felix S Dube, Catherine Bi Okoi, Amadou Diop, Aliou Thiongane, Madikay Senghore, Peter Ndow, Archibal Worwui, Papa M Faye, Baidy Dieye and 8 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mouhamadou A SonkoCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Felix S DubeWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Catherine Bi OkoiWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Amadou DiopCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Aliou ThionganeCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Madikay SenghoreWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Peter NdowWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Archibal WorwuiWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Papa M FayeCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Baidy DieyeCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Idrissa D BaCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Aliou DialloWorld Health Organization Country Office, Dakar, Senegal.
Diop BolyMinistry of Health, Dakar, Senegal.
Ousmane NdiayeCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Moussa F CisséCentre Hospitalier National d'Enfants Albert Royer, Dakar, Senegal.
Jason M MwendaWorld Health Organization, Regional Office for Africa, Immunization, Vaccines, and Development, Brazzaville, Congo.
Brenda A Kwambana-AdamsWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.
Martin AntonioWorld Health Organization Regional Reference Laboratory, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundBacterial meningitis is a major cause of mortality among children under 5 years of age. Senegal is part of World Health Organization-coordinated sentinel site surveillance for pediatric bacterial meningitis surveillance. We conducted this analysis to describe the epidemiology and etiology of bacterial meningitis among children less than 5 years in Senegal from 2010 and to 2016.

methodsChildren who met the inclusion criteria for suspected meningitis at the Centre Hospitalier National d'Enfants Albert Royer, Senegal, from 2010 to 2016 were included. Cerebrospinal fluid specimens were collected from suspected cases examined by routine bacteriology and molecular assays. Serotyping, antimicrobial susceptibility testing, and whole-genome sequencing were performed.

resultsA total of 1013 children were admitted with suspected meningitis during the surveillance period. Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus accounted for 66% (76/115), 25% (29/115), and 9% (10/115) of all confirmed cases, respectively. Most of the suspected cases (63%; 639/1013) and laboratory-confirmed (57%; 66/115) cases occurred during the first year of life. Pneumococcal meningitis case fatality rate was 6-fold higher than that of meningococcal meningitis (28% vs 5%). The predominant pneumococcal lineage causing meningitis was sequence type 618 (n = 7), commonly found among serotype 1 isolates. An ST 2174 lineage that included serotypes 19A and 23F was resistant to trimethoprim-sulfamethoxazole.

conclusionsThere has been a decline in pneumococcal meningitis post-pneumococcal conjugate vaccine introduction in Senegal. However, disease caused by pathogens covered by vaccines in widespread use still persists. There is need for continued effective monitoring of vaccine-preventable meningitis.

Indexed as

Sentinel SurveillanceChild, PreschoolFemaleHaemophilus influenzaeHumansInfantInfant, NewbornMaleMeningitis, BacterialNeisseria meningitidisPneumococcal VaccinesSenegalSerotypingStreptococcus pneumoniaeTrimethoprim, Sulfamethoxazole Drug CombinationVaccines, ConjugatePneumococcal VaccinesTrimethoprim, Sulfamethoxazole Drug CombinationVaccines, ConjugateHaemophilus influenzae type bNeisseria meningitidispediatric bacterial meningitispneumococcal conjugate vaccinesStreptococcus pneumoniae

Identifiers

PMID31505635
PMCPMC6761315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.